Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

27.3%

3 terminated/withdrawn out of 11 trials

Success Rate

62.5%

-24.0% vs industry average

Late-Stage Pipeline

55%

6 trials in Phase 3/4

Results Transparency

100%

5 of 5 completed trials have results

Key Signals

1 recruiting5 with results

Enrollment Performance

Analytics

Phase 3
6(60.0%)
Phase 2
3(30.0%)
Phase 1
1(10.0%)
10Total
Phase 3(6)
Phase 2(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)